Table 2.
Model 1 | Model 2 | |
---|---|---|
| ||
OR (95% CI) | OR (95% CI) | |
Clinical characteristics | ||
Outpatient (Yes) | 0.80 (0.45, 1.43) | 0.80 (0.43, 1.48) |
Previous treatment history | 0.40 (0.22, 0.71) | 0.43 (0.23, 0.82) |
Dual disorders | 2.84 (1.44, 5.62) | 2.64 (1.28, 5.42) |
Abstinence self-efficacy | 0.98 (0.96, 0.99) | 0.98 (0.96, 0.99) |
Trauma symptoms | 1.01 (0.996, 1.02) | 1.01 (0.99, 1.02) |
| ||
Personal network characteristics at T3 | ||
# of treatment related alters | 0.95 (0.88,1.02) | |
# of substance using alters | 1.08 (1.02, 1.14) | |
# of alters providing concrete support | 1.04 (0.99, 1.09) | |
# of alters providing sobriety support | 0.95 (0.88, 1.03) | |
# of critical alters | 1.17 (0.89, 1.54) | |
# of reciprocal relationships | 0.98 (0.92, 1.04) | |
# of very close alters | 0.99 (0.93, 1.05) | |
Density | 0.98 (0.97, 0.998) | |
Isolates | 0.92 (0.86, 0.99) | |
Components | 1.26 (0.84, 1.88) |
Note. Model 1, χ2(5) = 38.14, p < .001. Pseudo R2 = .126; Model 2, χ2(15) = 71.06, p < .001. Pseudo R2 = .221, Δχ2(10) = 32.92, p <.001